Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Availability of data and material Not applicable
Well-designed randomized clinical studies are needed to systematically evaluate the evidence for the use of these hepatoprotective agents as treatment options for APAP-induced liver injury, to determine the timing of initiation of the therapy, and to further define the optimal treatment regimen
The numbered markings typically show 10, 20, 30, 40, 50, 60, 70, 80, 90, 100
5Use the reconstituted solution within 28 days for optimal potency and safety
US$ 26.70
US$ 26.87
US$ 22.93
US$ 23.99
US$ 23.69
US$ 21.21
US$ 23.96
